Idh1 And Idh2 - Histology

Relevant Publications

Epigenetic dysregulation in cancers by isocitrate dehydrogenase 2 (IDH2).

Issue Release: 2024

Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives.

Issue Release: 2024

Clinical and radiological response of Maffucci related enchondromas to mutant IDH1 inhibitor Ivosidenib.

Issue Release: 2024

Targeting IDH1-Mutated Oligodendroglioma with Acid Ceramidase Inhibitors.

Issue Release: 2024

How to incorporate new agents into precise medicine for cholangiocarcinoma?

Issue Release: 2024

IDH inhibition in gliomas: from preclinical models to clinical trials.

Issue Release: 2024

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.

Issue Release: 2024

FDA approves IDH1 and IDH2 inhibitor for brain cancer.

Issue Release: 2024

Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT.

Issue Release: 2024

Neomorphic IDH Heterodimer Mutants: An Underestimated Point in Cancer Pathogenesis.

Issue Release: 2024

Enhancement of de novo lipogenesis by the IDH1 and IDH2-dependent reverse TCA cycle maintains the growth and angiogenic capacity of bone marrow-derived endothelial progenitor cells under hypoxia.

Issue Release: 2024

Data-driven modeling of core gene regulatory network underlying leukemogenesis in IDH mutant AML.

Issue Release: 2024

Giant skull base periosteal chondroma treated with endonasal endoscopic surgery: illustrative case.

Issue Release: 2024

Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.

Issue Release: 2024

Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone?

Issue Release: 2024

Mutant IDH modulates suppressive myeloid populations in malignant glioma.

Issue Release: 2024

Genetic and molecular backgrounds of the development of glioblastoma

Issue Release: 2024

Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?

Issue Release: 2024

Synthetic lethality between toxic amino acids, RTG-target genes and chaperones in Saccharomyces cerevisiae.

Issue Release: 2024

Toxicological assessment of cadmium exposure through Hyphantria cunea larvae on the predation fitness of Arma chinensis.

Issue Release: 2024

How do data protection laws impact histology practices?

What is Renal Artery Stenosis?

What is a Quality Management System (QMS) in Histology?

What Are the Histological Features of Transformed Cells?

What Are the Histological Features of Ataxia-Telangiectasia?

What are the Signs of Burnout?

How do imaging techniques influence histological studies?

Can Personality be Linked to Specific Brain Structures?

How Do Mutations Affect Amino Acid Sequences and Their Study in Histology?

What Challenges are Associated with Edge Computing in Histology?

Partnered Content Networks

Relevant Topics